Nowadays, L-glutamine is seen as a potential nutraceutical for AF treatment, as it stabilizes the microtubule network by enhancing HSP expression in degenerative and inflammatory diseases [126,127]. This evidence concerns the gene HSP90B2P and atrial fibrillation.